AGC Biologics is sounding the alarm on a projected “microbial manufacturing crunch” as demand for large-scale fermentation capacity sharply increases. | AGC Biologics’ Dieter Kramer shares insights, d ...
Biocytogen’s partner Ideaya Biosciences receives US FDA clearance to initiate phase 1 trial of IDE034, a potential first-in-class B7H3/ PTK7 bispecific ADC: Beijing Monday, Dece ...
Breakthrough Properties is raising a $1.5B fund to buy discounted lab assets as the market struggles with high vacancy and ...
The Cyprus Research and Innovation Centre (CyRIC), as coordinator of the MultiLab project, which operates under the EU’s Horizon Europe programme, on Monday announced the successful delivery of its ...
All three major US indices are poised to end the year near record highs in what is turning out to be a blockbuster year for stocks.
As the world enters an era of geopolitical uncertainty, political polarization and rapid technological change, China is ...
From booming ethanol orders to brewery expansion, everything seemed perfectly aligned for its next phase of growth, until the rally reversed and the share collapsed over 60 percent, leaving the market ...
Governor Jim Pillen is announcing a major milestone in Nebraska’s efforts to ensure all areas of the state have robust and ...
Total consideration upon satisfaction of closing conditions will be approximately $4 million in ICG equity Up to US$5 million in additional ...